Almost half of U.S. executives working in or close to the C-suite, 44.7%, see AI as the emerging technology most likely to put their internal-control systems at risk over the next 12 months.

This week has seen a cluster of healthcare-related business moves valued in the billions with a B.

Generative AI of the “large language” kind has been an attention hog over the past 10 or 11 months. The buzz has been so loud and constant that it’s all but asking to be dismissed as hype.

Do you know who owns your personal favorite doctor’s practice? Could it be a healthcare conglomerate? An insurance company? A private equity firm? Amazon?

It’s easy to see the appeal of cross-market hospital mergers to the marrying partners. How these long-distance entwinements help patients is a separate question.

Patients browsing shoppable hospital services often get one price online and another over the phone, new research shows.

Last week brought the latest in an occasional series of conversations on AI between governmental leaders and Big Tech honchos.

A healthcare logo familiar to Americans since the 1800s has gotten a makeover.